title: Pneumonia in low and middle income countries: progress and challenges.
abstract: Pneumonia remains the leading cause of childhood mortality and the most common reason for adult hospitalisation in low and middle income countries, despite advances in preventative and management strategies. In the last decade, pneumonia mortality in children has fallen to approximately 1.3 million cases in 2011, with most deaths occurring in low income countries. Important recent advances include more widespread implementation of protein-polysaccharide conjugate vaccines against Haemophilus influenzae type B and Streptococcus pneumoniae, implementation of case-management algorithms and better prevention and treatment of HIV. Determining the aetiology of pneumonia is challenging in the absence of reliable diagnostic tests. High uptake of new bacterial conjugate vaccines may impact on pneumonia burden, aetiology and empiric therapy but implementation in immunisation programmes in many low and middle income countries remains an obstacle. Widespread implementation of currently effective preventative and management strategies for pneumonia remains challenging in many low and middle income countries.
authors: Department of Paediatrics and Child Health, Red Cross War Memorial Childrens Hospital, University of Cape Town, , Cape Town, South Africa.
authors: H J
authors: HJ
authors: Zar
authors: S A
authors: SA
authors: Madhi
authors: S J
authors: SJ
authors: Aston
authors: S B
authors: SB
authors: Gordon
mesh_terms: D003906:Developing Countries; D006801:Humans; D009017:Morbidity / Q000639:trends; D011014:Pneumonia / Q000453:epidemiology*; D015996:Survival Rate / Q000639:trends
keywords: Pneumonia
references: Respir Med. 1995 Mar;89(3):187-92
references: 7746911
references: N Engl J Med. 2012 May 17;366(20):1881-90
references: 22591294
references: Eur Respir J. 1998 Jul;12(1):113-5
references: 9701424
references: Clin Infect Dis. 2010 Jul 15;51(2):189-94
references: 20540621
references: Bull World Health Organ. 2008 May;86(5):390-398C
references: 18545742
references: N Engl J Med. 2003 Oct 2;349(14):1341-8
references: 14523142
references: mBio. 2011 Jan 25;2(1):e00309-10
references: 21264063
references: Lancet Infect Dis. 2011 Oct;11(10):760-8
references: 21621466
references: BMC Infect Dis. 2012 Jan 10;12:3
references: 22233322
references: Pediatr Infect Dis J. 2011 Aug;30(8):669-74
references: 21407145
references: BMC Infect Dis. 2009 Mar 18;9:31
references: 19292931
references: Lancet. 2001 Aug 25;358(9282):619-24
references: 11530148
references: Lancet. 2000 Jun 17;355(9221):2106-11
references: 10902624
references: N Engl J Med. 2011 Oct 13;365(15):1406-16
references: 21995388
references: N Engl J Med. 2010 Mar 4;362(9):812-22
references: 20200385
references: N Engl J Med. 1995 Sep 28;333(13):845-51
references: 7651475
references: Thorax. 2010 Feb;65(2):101-6
references: 19703825
references: Lancet. 2013 Apr 20;381(9875):1405-1416
references: 23582727
references: Pediatr Infect Dis J. 2010 Dec;29(12):1099-04
references: 21155174
references: Int J Tuberc Lung Dis. 2010 Nov;14(11):1362-8
references: 20937173
references: Int J Epidemiol. 2010 Apr;39 Suppl 1:i155-71
references: 20348118
references: Clin Infect Dis. 2012 Apr;54 Suppl 2:S124-31
references: 22403226
references: Clin Infect Dis. 2008 Dec 15;47(12):1571-4
references: 18991510
references: Lancet. 2013 Apr 20;381(9875):1417-1429
references: 23582723
references: Curr Opin Pulm Med. 2010 May;16(3):208-16
references: 20375782
references: Lancet Infect Dis. 2010 Feb;10(2):83-92
references: 20113977
references: Eur Respir J. 2009 Jan;33(1):153-9
references: 18768577
references: Lancet. 2011 Nov 19;378(9805):1796-803
references: 22078721
references: Nat Med. 2004 Aug;10(8):811-3
references: 15247911
references: Lancet Infect Dis. 2003 Sep;3(9):547-56
references: 12954560
references: Lancet. 2000 Apr 8;355(9211):1225-30
references: 10770305
references: Int J Infect Dis. 2010 Jan;14(1):e22-7
references: 19586789
references: Clin Infect Dis. 2005 May 15;40(10):1511-8
references: 15844075
references: Lancet. 2013 Apr 20;381(9875):1380-1390
references: 23369797
references: PLoS Med. 2013;10(3):e1001400
references: 23554578
references: Clin Infect Dis. 2003 Feb 15;36(4):389-95
references: 12567294
references: PLoS One. 2012;7(10):e47926
references: 23112872
references: Clin Infect Dis. 2012 Apr;54 Suppl 2:S102-8
references: 22403223
references: Am J Med. 2006 Oct;119(10):865-71
references: 17000218
references: J Antimicrob Chemother. 2010 Apr;65(4):608-18
references: 20179023
references: N Engl J Med. 2013 Jul 11;369(2):155-63
references: 23841730
references: PLoS One. 2012;7(1):e29219
references: 22291887
references: N Engl J Med. 2007 Feb 15;356(7):685-96
references: 17301299
references: HIV Med. 2011 Oct;12(9):553-61
references: 21535347
references: Chest. 2010 Aug;138(2):279-83
references: 20382718
references: Clin Infect Dis. 2013 Jan;56(2):291-9
references: 23024291
references: Eur J Emerg Med. 2011 Oct;18(5):244-50
references: 21394031
references: J Infect Dis. 2010 Jan 1;201(1):32-41
references: 19947881
references: Pediatr Infect Dis J. 2013 Apr;32(4):330-4
references: 23337901
references: BMC Public Health. 2011 Apr 13;11 Suppl 3:S28
references: 21501446
references: Lancet. 2010 May 1;375(9725):1545-55
references: 20399493
references: Thorax. 2011 Sep;66(9):815-22
references: 20965930
references: Indian J Med Res. 2012 Apr;135(4):459-68
references: 22664492
references: N Engl J Med. 2012 Nov 8;367(19):1821-8
references: 23134382
references: Lancet. 2012 Feb 25;379(9817):729-37
references: 22285055
references: Lancet. 2011 Apr 9;377(9773):1264-75
references: 21435708